These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 8838511
1. High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study. Schroeder JO, Zeuner RA, Euler HH, Löffler H. J Rheumatol; 1996 Jan; 23(1):71-5. PubMed ID: 8838511 [Abstract] [Full Text] [Related]
2. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Perricone R, De Carolis C, Kröegler B, Greco E, Giacomelli R, Cipriani P, Fontana L, Perricone C. Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976 [Abstract] [Full Text] [Related]
3. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus]. Francioni C, Fioravanti A, Gelli R, Megale F, Marcolongo R. Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034 [Abstract] [Full Text] [Related]
4. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study. Villegas-Zambrano N, Martínez-Taboada VM, Bolívar A, San Martín M, Alvarez L, Marín MJ, López-Hoyos M. Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133 [Abstract] [Full Text] [Related]
5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G. Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [Abstract] [Full Text] [Related]
6. Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement. Agnello V, Pariser K, Gell J, Gelfand J, Turksoy RN. J Rheumatol; 1983 Oct; 10(5):682-7. PubMed ID: 6606038 [Abstract] [Full Text] [Related]
7. Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: a 12-month prospective study. Zonana-Nacach A, Salas M, Sánchez ML, Camargo-Coronel A, Bravo-Gatica C, Mintz G. J Rheumatol; 1995 Jan; 22(1):45-9. PubMed ID: 7699680 [Abstract] [Full Text] [Related]
8. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA. Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950 [Abstract] [Full Text] [Related]
9. Hyperprolactinemia in males with systemic lupus erythematosus. Mok CC, Lau CS, Lee KW, Wong RW. J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430 [Abstract] [Full Text] [Related]
10. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences]. Pirner K, Rubbert A, Burmester GR, Kalden JR, Manger B. Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742 [Abstract] [Full Text] [Related]
11. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study. Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA. Maturitas; 2009 Mar 20; 62(3):311-6. PubMed ID: 19193505 [Abstract] [Full Text] [Related]
12. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases]. Chen JL, Huang XM, Zeng XJ, Wang Y, Zhou MX, Ma YH, Li RS, Shen T. Zhonghua Yi Xue Za Zhi; 2007 May 22; 87(19):1330-3. PubMed ID: 17727778 [Abstract] [Full Text] [Related]
13. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Petri M, Jones RJ, Brodsky RA. Arthritis Rheum; 2003 Jan 22; 48(1):166-73. PubMed ID: 12528116 [Abstract] [Full Text] [Related]
14. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. Toubi E, Kessel A, Shoenfeld Y. Hum Immunol; 2005 Apr 22; 66(4):395-402. PubMed ID: 15866703 [Abstract] [Full Text] [Related]
15. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Arthritis Rheum; 2005 May 22; 52(5):1491-503. PubMed ID: 15880830 [Abstract] [Full Text] [Related]
16. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease. Becker BN, Fuchs H, Hakim R. J Am Soc Nephrol; 1995 Apr 22; 5(10):1746-50. PubMed ID: 7787141 [Abstract] [Full Text] [Related]
17. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial. Muller S, Monneaux F, Schall N, Rashkov RK, Oparanov BA, Wiesel P, Geiger JM, Zimmer R. Arthritis Rheum; 2008 Dec 22; 58(12):3873-83. PubMed ID: 19035498 [Abstract] [Full Text] [Related]
18. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases. Winder A, Molad Y, Ostfeld I, Kenet G, Pinkhas J, Sidi Y. J Rheumatol; 1993 Mar 22; 20(3):495-8. PubMed ID: 8478856 [Abstract] [Full Text] [Related]
19. [High dose intravenous immunoglobulins in treating systemic lupus erythematosus-associated thrombocytopenia]. Zhang X, Dong Y, Tang F, Zhang F, Li H. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb 22; 22(1):82-4. PubMed ID: 12903501 [Abstract] [Full Text] [Related]
20. The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus. Peralta-Ramírez MI, Jiménez-Alonso J, Godoy-García JF, Pérez-García M, Group Lupus Virgen de las Nieves. Psychosom Med; 2004 Feb 22; 66(5):788-94. PubMed ID: 15385708 [Abstract] [Full Text] [Related] Page: [Next] [New Search]